13F-HR filed by AJU IB Investment Co., Ltd.
AJU IB Investment Co., Ltd. filed this 13F-HR for the quarter ended 2025-12-31, filed 2026-02-10, with 7 holding rows worth $22,787,545.
- Accession
- 0001140361-26-004468
- Filer
- CIK 1710065
- Filed
- 2026-02-10
- Accepted by EDGAR
- acceptance time not in the bulk data set
- Ingested
- Source
- SEC quarterly data set
13F report for Q4 2025
A holdings report, 7 entries on the cover page, a total value of $22,787,545 stated on the cover page (in dollars after the unit check, H1), rows summing to $22,787,545 with VALUE read as dollars as filed, 13F file number 028-21185. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| ARCELLX INC COMMON STOCK | 03940C100 | Stock | 223,486 | $14,571,287 | dollars as filed | |
| RALLYBIO CORP | 75120L100 | COM | 754,678 | $4,142,277 | dollars as filed | |
| KYMERA THERAPEUTICS INC | 501575104 | COM | 19,648 | $1,528,811 | dollars as filed | |
| SEER INC | 81578P106 | COM CL A | 816,375 | $1,493,966 | dollars as filed | |
| Xilio Therapeutics Inc. | 98422T100 | COM | 667,742 | $427,488 | dollars as filed | |
| RAPT THERAPEUTICS INC | 75382E109 | COM | 12,437 | $421,241 | dollars as filed | |
| SUTRO BIOPHARMA INC | 869367102 | COM | 17,500 | $202,475 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001140361-26-004468 | this filing | 2026-02-10 | acceptance time not in the bulk data set |